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Anthropometric traits, such as body weight and height, have been shown to impact breast cancer 
risk.  Body mass index (BMI) is negatively associated, and height is positively associated, with 
breast cancer risk in premenopausal women.  Less studied is the impact of changes in BMI over 
time, however, or of the impact of anthropometric traits on molecular subtypes of breast cancer, 
which have distinct biologies and unique etiologies.  Given that some of the more aggressive breast 
cancer subtypes are associated with age, evaluating the effect of these anthropomorphic traits on 
risk of breast cancer subtypes in young women may be useful.  In a recent study published in 
Cancer, Drs. Masaaki Kawai and Christopher Li in the Public Health Sciences Division report that 
changes in BMI since age 18 do impact breast cancer risk for some molecular subtypes of breast 
cancer, but not others.  Additionally, the authors also found that these associations may depend on 
whether or not a woman has ever had a live birth (parity status). 
To evaluate these questions, the authors analyzed data from a Seattle-based cohort study 
investigating breast cancer risk in women aged 20-44 (Li et al., 2012).  Breast cancer cases were 
grouped into three categories, based on the molecular subtype of the breast cancer: ER-positive 
(estrogen receptor positive), ER-negative/HER2-positive (estrogen receptor negative, human 
epidermal growth factor receptor 2 positive), and triple-negative (estrogen receptor negative, human 
epidermal growth factor receptor 2 negative, and progesterone receptor negative).  The authors then 
evaluated the association between various anthropometric traits and each of these molecular 
subtypes. 
Overall, the authors found no association between height, BMI at age 18, or recent BMI for any of 
the molecular subtypes.  However, the authors did find an association when evaluating changes in 
BMI since age 18.  Weight gain since age 18 was associated with a 7% increased risk of triple-
negative breast cancer per 1 unit increase in BMI (odds ratio 1.07, 95% confidence interval 1.02-
1.11).  Furthermore, when compared to a BMI change less than 5 units, a BMI change of 10 or more 
was associated with a two-fold increased risk of triple-negative breast cancer (odds ratio 2.0, 95% 
confidence interval 1.2-3.3).  According to Dr. Masaaki Kawai, the post-doctoral fellow who led the  
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study, "these results suggest that weight gain may be associated with risk of an aggressive type of 
breast cancer."  
Since prior studies have identified differences in the risk associated with various reproductive and 
lifestyle characteristics across molecular subtypes of breast cancer, the authors further evaluated 
the potential impact of these additional factors.  Of these, parity (whether or not a woman had ever 
had a live birth) was found to significantly modify the association between BMI change and the risk 
of ER-positive breast cancer (see figure).  BMI change since age 18 was associated with a 
decreased risk of ER-positive breast cancer in nulliparous women (those who never had a live birth), 
but no association was observed in parous women (those who had at least one live birth).  The 
opposite was observed for triple-negative breast cancer, where a positive association was observed 
in parous women, but not among nulliparous women.   
While these results are interesting, said Kawai, "the underlying biological mechanisms are largely 
unknown."  Obesity exerts a range of biologic effects, including on hormone and insulin-like growth 
factor-I levels, and the inverse association between BMI and premenopausal breast cancer risk 
overall is primarily hormonally driven.  It is possible that the subtype-specific inverse association 
observed in this study may reflect that changes in breast tissue induced by pregnancy outweigh the 
effects of BMI on breast cancer risk.  As such, "these results require confirmation by other studies," 
said Kawai.  In the meantime, these results point to the potential insights that may be gained from 
investigating cancers according to their molecular subtypes. 
 
Other PHS investigators contributing to this project were Drs. Kathleen Malone and Mei-Tzu Tang. 
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Image provided by Dr. Jonathan Kocarnik 
Association between change in BMI since age 18 and molecular subtype of breast cancer, by parity 
status. Among parous women, BMI gain was associated with increased risk of triple-negative breast 
cancer. Among nulliparous women, BMI gain was associated with decreased risk of estrogen 
receptor-positive breast cancer. 
 
